Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gentherm (THRM) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Gentherm (THRM) over the last 16 years, with Q3 2025 value amounting to $9.3 million.

  • Gentherm's Gains from Investment Securities rose 3009.76% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year decrease of 130.82%. This contributed to the annual value of $21296.0 for FY2024, which is 8475.42% down from last year.
  • As of Q3 2025, Gentherm's Gains from Investment Securities stood at $9.3 million, which was up 3009.76% from $7.7 million recorded in Q2 2025.
  • In the past 5 years, Gentherm's Gains from Investment Securities registered a high of $9.3 million during Q3 2025, and its lowest value of $1.4 million during Q4 2024.
  • Its 5-year average for Gains from Investment Securities is $5.4 million, with a median of $5.2 million in 2025.
  • As far as peak fluctuations go, Gentherm's Gains from Investment Securities surged by 22427.26% in 2022, and later tumbled by 6879.0% in 2024.
  • Gentherm's Gains from Investment Securities (Quarter) stood at $2.5 million in 2021, then skyrocketed by 224.27% to $8.1 million in 2022, then tumbled by 46.17% to $4.4 million in 2023, then crashed by 68.79% to $1.4 million in 2024, then surged by 582.37% to $9.3 million in 2025.
  • Its Gains from Investment Securities stands at $9.3 million for Q3 2025, versus $7.7 million for Q2 2025 and $5.2 million for Q1 2025.